Associations between endometriosis and depression and/or anxiety : a population-based study using symptomatic and asymptomatic endometriosis patients

article OA: green CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-08-07

This study found a 15.8% prevalence of depression/anxiety in endometriosis patients and that both painful symptoms and inflammation contribute to this risk.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This population-based thesis linked British Columbia administrative databases (1998–2017) to assess the prevalence of depression and/or anxiety in a pathologically-confirmed endometriosis cohort and to estimate how these comorbidities relate to post-surgical treatment outcomes (physician visits, prescriptions, and reoperations). It found a 15.8% prevalence of depression and/or anxiety among endometriosis patients, and those with depression and/or anxiety had higher odds of reoperation, pelvic-pain–related physician visits, and prescriptions for hormonal medications and prescription-level analgesics. In comparisons across three groups (symptomatic endometriosis, symptomatic pelvic pain without endometriosis, and asymptomatic endometriosis), symptomatic pelvic pain without endometriosis had a higher risk than symptomatic endometriosis, while asymptomatic endometriosis did not significantly differ from symptomatic endometriosis, with the author noting that painful symptoms and inflammation may contribute. This paper is centrally about endometriosis—using symptomatic and asymptomatic endometriosis cohorts to quantify associations with depression and anxiety and their relationship to treatment outcomes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objectives: Endometriosis is a painful and inflammatory condition affecting approximately 10% of female people. The association between endometriosis, depression, and anxiety is well known, but the mechanism driving it, and its potential effects on treatment, remain elusive. This thesis aims to: 1) Determine the prevalence of depression and/or anxiety in a pathologically-confirmed endometriosis cohort and estimate how these co-morbid conditions may affect treatment outcomes; and 2) Estimate the depression and/or anxiety risk in three different groups of endometriosis or pelvic pain patients to better understand the mechanism between endometriosis and mental health. Methods: Population-based administrative databases in British Columbia were linked from 1998 to 2017. The prevalence of depression and/or anxiety was determined in those with pathologically-confirmed endometriosis. Descriptive statistics and logistic regression were used to estimate effects on treatment outcomes following surgery, such as physician visits, prescriptions, and reoperations. Then the cohort was split into three groups based on their symptomology and diagnoses (Group 1 – symptomatic endometriosis patients, Group 2 – symptomatic patients without endometriosis, and Group 3 – asymptomatic endometriosis patients). Cox proportional hazards models were used to estimate each group’s depression and/or anxiety risk. Results: Pathologically-confirmed endometriosis patients had a 15.8% prevalence of depression and/or anxiety. Patients with depression and/or anxiety had a higher odds of having a reoperation, visiting a physician for pelvic pain, and being prescribed hormonal medications and prescription-level analgesics. When comparing our three groups, Group 2 had a higher risk of depression and/or anxiety compared to Group 1. Additionally, Group 3 had no significant difference in risk compared to Group 1. This confirms that both the painful symptoms of endometriosis and its inflammatory nature could be contributing to the risk for depression and/or anxiety. Conclusion: Our results support and contribute to the growing evidence that endometriosis is a systemic condition. We observed a high prevalence of depression and/or anxiety in this cohort and higher odds of reoperation and pain-related health services use in these individuals. Further, both painful symptoms and inflammation appear to be factors in the risk for depression and/or anxiety. Therefore, systemic care, with consideration for mental well-being, should be part of endometriosis treatment.
Full text 6,437 characters · extracted from oa-html · 8 sections · click to expand

Abstract

Objectives: Endometriosis is a painful and inflammatory condition affecting approximately 10% of female people. The association between endometriosis, depression, and anxiety is well known, but the mechanism driving it, and its potential effects on treatment, remain elusive. This thesis aims to: 1) Determine the prevalence of depression and/or anxiety in a pathologically-confirmed endometriosis cohort and estimate how these co-morbid conditions may affect treatment outcomes; and 2) Estimate the depression and/or anxiety risk in three different groups of endometriosis or pelvic pain patients to better understand the mechanism between endometriosis and mental health.

Methods

Population-based administrative databases in British Columbia were linked from 1998 to 2017. The prevalence of depression and/or anxiety was determined in those with pathologically-confirmed endometriosis. Descriptive statistics and logistic regression were used to estimate effects on treatment outcomes following surgery, such as physician visits, prescriptions, and reoperations. Then the cohort was split into three groups based on their symptomology and diagnoses (Group 1 – symptomatic endometriosis patients, Group 2 – symptomatic patients without endometriosis, and Group 3 – asymptomatic endometriosis patients). Cox proportional hazards models were used to estimate each group’s depression and/or anxiety risk.

Results

Pathologically-confirmed endometriosis patients had a 15.8% prevalence of depression and/or anxiety. Patients with depression and/or anxiety had a higher odds of having a reoperation, visiting a physician for pelvic pain, and being prescribed hormonal medications and prescription-level analgesics. When comparing our three groups, Group 2 had a higher risk of depression and/or anxiety compared to Group 1. Additionally, Group 3 had no significant difference in risk compared to Group 1. This confirms that both the painful symptoms of endometriosis and its inflammatory nature could be contributing to the risk for depression and/or anxiety.

Conclusion

Our results support and contribute to the growing evidence that endometriosis is a systemic condition. We observed a high prevalence of depression and/or anxiety in this cohort and higher odds of reoperation and pain-related health services use in these individuals. Further, both painful symptoms and inflammation appear to be factors in the risk for depression and/or anxiety. Therefore, systemic care, with consideration for mental well-being, should be part of endometriosis treatment. Item Metadata | Title | Associations between endometriosis and depression and/or anxiety : a population-based study using symptomatic and asymptomatic endometriosis patients | | Creator | | | Supervisor | | | Publisher | University of British Columbia | | Date Issued | 2023 | | Description |

Objectives

Endometriosis is a painful and inflammatory condition affecting approximately 10% of female people. The association between endometriosis, depression, and anxiety is well known, but the mechanism driving it, and its potential effects on treatment, remain elusive. This thesis aims to: 1) Determine the prevalence of depression and/or anxiety in a pathologically-confirmed endometriosis cohort and estimate how these co-morbid conditions may affect treatment outcomes; and 2) Estimate the depression and/or anxiety risk in three different groups of endometriosis or pelvic pain patients to better understand the mechanism between endometriosis and mental health.

Methods

Population-based administrative databases in British Columbia were linked from 1998 to 2017. The prevalence of depression and/or anxiety was determined in those with pathologically-confirmed endometriosis. Descriptive statistics and logistic regression were used to estimate effects on treatment outcomes following surgery, such as physician visits, prescriptions, and reoperations. Then the cohort was split into three groups based on their symptomology and diagnoses (Group 1 – symptomatic endometriosis patients, Group 2 – symptomatic patients without endometriosis, and Group 3 – asymptomatic endometriosis patients). Cox proportional hazards models were used to estimate each group’s depression and/or anxiety risk.

Results

Pathologically-confirmed endometriosis patients had a 15.8% prevalence of depression and/or anxiety. Patients with depression and/or anxiety had a higher odds of having a reoperation, visiting a physician for pelvic pain, and being prescribed hormonal medications and prescription-level analgesics. When comparing our three groups, Group 2 had a higher risk of depression and/or anxiety compared to Group 1. Additionally, Group 3 had no significant difference in risk compared to Group 1. This confirms that both the painful symptoms of endometriosis and its inflammatory nature could be contributing to the risk for depression and/or anxiety.

Conclusion

Our results support and contribute to the growing evidence that endometriosis is a systemic condition. We observed a high prevalence of depression and/or anxiety in this cohort and higher odds of reoperation and pain-related health services use in these individuals. Further, both painful symptoms and inflammation appear to be factors in the risk for depression and/or anxiety. Therefore, systemic care, with consideration for mental well-being, should be part of endometriosis treatment. | | Genre | | | Type | | | Language | eng | | Date Available | 2025-03-31 | | Provider | Vancouver : University of British Columbia Library | | Rights | Attribution-NonCommercial-NoDerivatives 4.0 International | | DOI | 10.14288/1.0436903 | | URI | | | Degree (Theses) | | | Program (Theses) | | | Affiliation | | | Degree Grantor | University of British Columbia | | Graduation Date | 2023-11 | | Campus | | | Scholarly Level | Graduate | | Rights URI | | | Aggregated Source Repository | DSpace | Item Media Item Citations and Data Rights Attribution-NonCommercial-NoDerivatives 4.0 International

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T10:54:03.425909+00:00
License: CC0 · commercial use OK